Skip to content
buyModerate cluster of 4

Foresite Labs, LLC bought $202k of ALMS

owner at ALUMIS INC.. 45,000 shares at an average of $4.50, traded May 2, 2025, filed May 6, 2025.

Conviction score
42
Value
$202k
45,000 shares
Holdings after
4,247,670
+1% from before
From 52-week low
+29%
low $3.57, close $4.59
From 52-week high
-65%
high $12.98, as of May 2, 2025

Score components

  • Role
    10% owner
    +12
  • Trade size
    $202k at market
    +12
  • Relative to holdings
    Holdings up 1.1%
    0
  • Price context
    65% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -23.0%, 3m -3.4%, 6m +4.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ALMSOct 9, 2026 · close 7.16
Since filing May 6, 2025: +64.6%SPY +41.6% · excess +23.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-25-045221, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 2, 2025POpen-market purchase
Common Stockindirect: See Footnote
+25,000$4.62$116k4,227,670May 6, 2025
May 6, 2025POpen-market purchase
Common Stockindirect: See Footnote
+20,000$4.34$87k4,247,670May 6, 2025

Related signals

Other insiders at ALUMIS INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
46Moderate
ALMSbuy
ALUMIS INC.
Srinivas Akkaraju
director
$11M
986,721 shares
+22%
40Moderate
ALMSsell
ALUMIS INC.
Srinivas Akkaraju
director
$1.0M
96,131 shares
-2%
38Weak
ALMSsell 6
ALUMIS INC.
Roy C. Hardiman
Chief Business & Strategy Ofcr
$71k
2,692 shares
-1%
51Moderate
ALMSsell 6
ALUMIS INC.
John R. Schroer
Chief Financial Officer
$87k
3,282 shares
-12%
38Weak
ALMSsell 6
ALUMIS INC.
David M Goldstein
Chief Scientific Officer
$68k
2,596 shares
-8%
38Weak
ALMSsell 6
ALUMIS INC.
Jorn Drappa
Chief Medical Officer
$65k
2,447 shares
-4%
38Weak
ALMSsell 6
ALUMIS INC.
Mark Christopher Bradley
Chief Development Officer
$68k
2,572 shares
-5%
41Moderate
ALMSsell 6
ALUMIS INC.
Sanam Pangali
Chief Legal Officer
$36k
1,364 shares
-12%
21Weak
ALMSsell
ALUMIS INC.
Sanam Pangali
Chief Legal Officer
$140k
5,000 shares
-31%
66Notable
ALMSbuy 4
ALUMIS INC.
Srinivas Akkaraju
director
$10.0M
588,235 shares
+46%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Foresite Labs, LLC bought $202k of ALMS | InsiderTell